Lessons from antineoplaston

  title={Lessons from antineoplaston},
  author={James B Fahner},
  journal={The Lancet},
SIR—Your March 15 editorial encourages a rapprochement of orthodox oncology and complementary therapy, but some important issues are overlooked. We must remember the spectrum of unproven treatments. At the worst end are the purveyors of useless or harmful remedies who cynically make millions on the backs of patients made vulnerable through serious illness. This is not complementary to anything but fraud. No comparison is possible with physicians’ efforts to comply with current medical practice… CONTINUE READING

Topics from this paper.